Organon (1OGN) Stock Statistics & Valuation Metrics
Total Valuation
Organon has a market cap or net worth of EUR 3.24B. The enterprise value is EUR 11.08B.
- Market Cap
- EUR 3.24B
- Enterprise Value
- EUR 11.08B
Share Statistics
Organon has 262,609,440 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 262,609,440
- Owned by Insiders
- 0.34%
- Owned by Institutions
- 40.76%
Financial Efficiency
Organon’s return on equity (ROE) is 0.25 and return on invested capital (ROIC) is 5.37%.
- Return on Equity (ROE)
- 0.25
- Return on Assets (ROA)
- 0.01
- Return on Invested Capital (ROIC)
- 5.37%
- Return on Capital Employed (ROCE)
- 0.12
- Revenue Per Employee
- 621.60K
- Profits Per Employee
- 18.70K
- Employee Count
- 10,000
- Asset Turnover
- 0.48
- Inventory Turnover
- 2.03
Valuation Ratios
The current PE Ratio of Organon is 17.52. Organon’s PEG ratio is -0.30.
- PE Ratio
- 17.52
- PS Ratio
- 0.60
- PB Ratio
- 3.05
- Price to FCF
- 5.38
- Price to Operating Cash Flow
- 4.31
- PEG Ratio
- -0.30
Income Statement
In the last 12 months, Organon had revenue of 6.22B and earned 187.00M in profits. Earnings per share was 0.72.
- Revenue
- 6.22B
- Gross Profit
- 3.36B
- Operating Income
- 1.28B
- Pretax Income
- 425.00M
- Net Income
- 187.00M
- EBITDA
- 1.29B
- Earnings Per Share (EPS)
- 0.72
Cash Flow
In the last 12 months, operating cash flow was 843.00M and capital expenditures -168.00M, giving a free cash flow of 675.00M billion.
- Operating Cash Flow
- 843.00M
- Free Cash Flow
- 675.00M
- Free Cash Flow per Share
- 2.57
Dividends & Yields
Organon pays an annual dividend of ―, resulting in a dividend yield of 0.56%
- Dividend Per Share
- ―
- Dividend Yield
- 0.56%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 18.57%
- Earnings Yield
- 5.86%
Stock Price Statistics
- Beta
- 0.31
- 52-Week Price Change
- 114.84%
- 50-Day Moving Average
- 12.06
- 200-Day Moving Average
- 10.00
- Relative Strength Index (RSI)
- 67.13
- Average Volume (3m)
- 83
Important Dates
Organon upcoming earnings date is Feb 18, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 29, 2026
- Next Earnings Date
- Feb 18, 2027
- Ex-Dividend Date
- ―
Financial Position
Organon as a current ratio of 1.82, with Debt / Equity ratio of 1170.21%
- Current Ratio
- 1.82
- Quick Ratio
- 1.23
- Debt to Market Cap
- 4.67
- Net Debt to EBITDA
- 6.38
- Interest Coverage Ratio
- 2.55
Taxes
In the past 12 months, Organon has paid 238.00M in taxes.
- Income Tax
- 238.00M
- Effective Tax Rate
- 0.56
Enterprise Valuation
Organon EV to EBITDA ratio is 8.30, with an EV/FCF ratio of 15.90.
- EV to Sales
- 1.76
- EV to EBITDA
- 8.30
- EV to Free Cash Flow
- 15.90
- EV to Operating Cash Flow
- 12.73
Balance Sheet
Organon has EUR 1.46B in cash and marketable securities with EUR 8.55B in debt, giving a net cash position of -EUR 7.10B billion.
- Cash & Marketable Securities
- EUR 1.46B
- Total Debt
- EUR 8.55B
- Net Cash
- -EUR 7.10B
- Net Cash Per Share
- -EUR 27.03
- Tangible Book Value Per Share
- -EUR 15.33
Margins
Gross margin is 53.42%, with operating margin of 19.49%, and net profit margin of 3.49%.
- Gross Margin
- 53.42%
- Operating Margin
- 19.49%
- Pretax Margin
- 8.25%
- Net Profit Margin
- 3.49%
- EBITDA Margin
- 21.20%
- EBIT Margin
- 15.56%
Analyst Forecast
The average price target for Organon is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -8.00%
- EPS Growth Forecast
- -59.74%
Scores
- Smart Score
- 4
- AI Score
- ―